Lyon, France, September 7th, 2020 – 6:00 pm CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, announced today that CEO, Gérard Soula, will present a company overview at the H.C. Wainwright 22nd Annual
Adocia to Present Results of the 1st Phase Ib Study of M1Pram (ADO09) at the Annual Congress of the Société Francophone du Diabète (SFD) Adocia will deliver an oral presentation on the 1st Phase Ib Study of M1Pram (ADO09) (pramlintide insulin) at the Annual Congress of the Société Francophone du Diabète. The data were previously
👉 The INPI France patent list filed 2019 ranks Adocia in 4th place among French SMEs thanks to its 11 patents. Among the top 10 French SMEs, 4 are based in the Auvergne-Rhône-Alpes region. This annual ranking classifies companies by region and size. It has become a reference, highlighting the innovation effort made by the
Last November 14th, Thierry de Catheu and Alessandra Fra invited Adocia to be a guest speaker at the Biotech Agora Event in Paris. We warmly thank Thierry De Catheu and Alssandra Fra and all our shareholders who shared this moment with us! Find an extract of vidéo (French only) To read the Adocia Presentation proposed
Adocia-Analyse Department
In France, more than 3.5 million people live with diabetes. Eve-Marie, a person with type 1 diabetes, dreams of an insulin delivery system that could automatically manage her blood glucose. Part of the answer to that hope may lie in Adocia’s ultra-rapid insulin, which faster action, combined with better algorithms, could significantly improve daily diabetes
Gérard Soula, Adocia CEO
On World Diabetes Day, BFM TV highlighted “the everyday life” of a person with type 1 diabetes (PWD). Taking insulin at mealtime, or even after, is crucial for PWD because it allows marked improvement in the accuracy of the insulin dosage and the person’s quality of life. Gérard Soula, CEO of Adocia, explains how BioChaperone
This October 14th, Gérard Soula, Adocia CEO was interviewed following the Press Release: Adocia obtains additional financial resources to accelerate its growth. To watch the video produced by Didier Testot on the French Web TV: www.labourseetlavie.com
To listen to the Adocia conference call which was held on Friday August 23rd, following  the Press Release of the Arbitration decision, please, click on the link: ADOC UPDATE – English: https://edge.media-server.com/mmc/p/zqatu6o4 ADOC UPDATE – French: https://edge.media-server.com/mmc/p/k85cjxre  
Discover results of “Eloquence contest” of the 135th promotion of ESPCI Paris in video: Last April, Adocia, who sponsors the ESPCI Paris, proposed an eloquence contest with the theme: “Your industrial internship in 135 seconds”, dedicated to the 135th promotion of the 3rd year engineer-researcher internship. 22 students out of 100 responded! Congratulations to the
BIOTECHSCOPE® 2019 Roundup of J.P. Morgan’s Annual Healthcare Conference, Paris, France. At this occasion, Gerard Soula, Adocia CEO, is invited to participate in the roundtable organised by Biotech Finances and Neighborhood, the life sciences innovation center of VCLS (Voisin Consulting Life Sciences). Registration on the website link.   Place VCLS’s Innovation Center – Neighborhood 64